RossanoJWSinghTPCherikhWS, et al.The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report—2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38(10): 1028-1041.
2.
ColvinMSmithJMHadleyN, et al.OPTN/SRTR 2017 annual data report: heart. Am J Transplant. 2019;19(Supplement 2): 323-403.
3.
EdelsonJBHuangYGriffisH, et al.The influence of mechanical circulatory support on post-transplant outcomes in pediatric patients: a multicenter study from the International Society for Heart and Lung Transplantation (ISHLT) registry. J Heart Lung Transplant. 2021;40(11): 1443-1453.
4.
MoralesDLSAdachiIPengDM, et al.Fourth annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report. Ann Thorac Surg. 2020;110(6): 1819-1831.
5.
PengDMKoehlDACantorRS, et al.Outcomes of children with congenital heart disease implanted with ventricular assist devices: an analysis of the pediatric interagency registry for mechanical circulatory support (Pedimacs). J Heart Lung Transplant. 2019;38(4): 420-430.
6.
ScottWMoleskiM. Michael Polanyi: scientist and philosopher. Oxford University Press; 2005.
7.
MorganrothJBiggerJTAndersonJL. Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available. Am J Cardiol. 1990;65(1): 40-48.
8.
EchtDSLiebsonPRMitchellLB, et al.Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324(12): 781-788.
9.
WilsonRA. Feminine forever. Evans; 1968.
10.
YaffeKSawayaGLieberburgIGradyD. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279(9): 688-695.
11.
GradyDRubinSMPetittiDB, et al.Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117(12): 1016-1037.
12.
Committee* TWHIS. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's Health initiative randomized controlled trial. JAMA. 2004;291(14): 1701-1712.
13.
RossouwJAndersonGPrenticeR, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288(3): 321-333.
14.
HaritonELocascioJJ. Randomised controlled trials—the gold standard for effectiveness research. BJOG2018;125(13): 1716.
15.
MoralesDLSAlmondCSDJaquissRDB, et al.Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011;30(1): 1-8.
16.
FraserCDJaquissRDBRosenthalDN, et al.Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367(6): 532-541.
17.
ZafarFConwayJBleiweisMS, et al.Berlin Heart EXCOR and ACTION post-approval surveillance study report. J Heart Lung Transplant. 2021;40(4): 251-259.
18.
ShaddyREBoucekMMHsuDT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA2007;298(10): 1171.
19.
AdachiI. Current status and future perspectives of the PumpKIN trial. Transl Pediatr. 2018;7(2): 162-168.
20.
BaldwinJTAdachiITealJ, et al.Closing in on the PumpKIN trial of the Jarvik 2015 ventricular assist device. Semin Thorac Cardiovasc Surg Pediatr Card Surg. Annu. 2017;20: 9-15.
FelkerGMAnstromKJRogersJG. A global ranking approach to end points in trials of mechanical circulatory support devices. J Card Fail. 2008;14(5): 368-372.
23.
PallmannPBeddingAWChoodari-OskooeiB, et al. Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Med. 2018;16(1): 1-15.
24.
ShaddyRCanterCHalnonN, et al.Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). Am Heart J. 2017;193: 23-34.
25.
AngusDCAlexanderBMBerryS, et al. Adaptive platform trials: definition, design, conduct and reporting considerations. Nat Rev Drug Discov. 2019;18(10): 797-807.
26.
GordonACMounceyPRAl-BeidhF, et al.Interleukin-6 receptor antagonists in critically ill patients with covid-19. N Engl J Med. 2021;384(16): 1491-1502.
